Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients

December 22, 2012 updated by: Hurley Medical Center
The investigators hypothesize that the scheduled use of bronchoscopy on a regular basis after inhalation injury in burn patients will improve outcome by providing pulmonary hygiene, decrease the incidence of pneumonia, and detect pneumonia earlier than standard treatment without bronchoscopy.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The role of bronchoscopy in most hospitals has been limited to obtaining lavage fluid for culture and assessing the degree of airway injury, which has been shown to be predictive of outcome. Severe inhalation injury, which is characterized by pulmonary edema, bronchial edema, and secretions, can occlude the airway and lead to atelectasis and pneumonia. Aggressive use of bronchoscopy is highly effective in removing foreign particles and accumulated secretions that worsen the inflammatory response and impede ventilation. While it seems intuitive that bronchoscopy would improve pulmonary hygiene by removing secretions and denuded epithelial slough in burn patients, there has not been any published data to support or deter the use of bronchoscopy for inhalation injury nor document an improvement in morbidity or mortality secondary to bronchoscopy as a therapeutic intervention.

Recent research has shown that the process of intubation for mechanical ventilation provides a portal for bacterial contamination, after which the damaged tracheobronchial mucosa quickly becomes colonized with pathogenic organisms in over 50% of the patients. Furthermore, within 15 minutes of smoke inhalation, there is significant airway edema and thickening, more prominently in the lower trachea than the upper portion. These factors place the patient with inhalation injury at high risk for pneumonia.

We have used the National Burn Repository data to previously show that patients who receive aggressive use of bronchoscopy after inhalation injury have an improved outcome in terms of decreased ventilator days, decreased ICU length of stay, decreased incidence of pneumonia, and a trend towards improved mortality. However, that data was unable to document why. It was also unable to confirm that the findings were not due to institutional bias. Therefore, one of the conclusions from that study was that a prospective trial is needed to confirm the findings.

Our hypothesis is that a scheduled and sequential use of bronchoscopy after inhalation injury as a therapeutic tool to remove secretions, slough, carbonaceous material, and screen for the early detection of pneumonia by bronchoalveolar lavage (BAL) will improve outcome. We will attempt to document this improvement by using the following endpoints: length of ICU stay, length of hospital stay, ventilator days, incidence of pneumonia, overall morbidity and mortality with and without bronchoscopy.

Study Type

Interventional

Enrollment (Actual)

28

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Flint, Michigan, United States, 48503
        • Hurley Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Any burned patient arriving intubated on mechanical ventilation OR requiring mechanical ventilation within 48 hours of admission AND
  2. > 18 years old AND
  3. patient believed to be able to survive more than 48 hours after arrival (not likely to be made DNR or comfort care) including:

    • any methamphetamine explosion or
    • any burn associated with fire (not chemical) of the face or blast injury to the face or
    • confined in a burning space for more than 10 minutes or
    • any burn with carbonaceous material around the nose or mouth or
    • any burn > 15% TBSA associated with fire (not chemical) or
    • any burn associated with an explosion in a confined space.

Exclusion Criteria:

  1. Likely to die within 48 hours based upon severity of injury.
  2. Less than 18 years old.
  3. Burned patient transferred to our facility already on mechanical ventilation for more than 48 hours.
  4. Patient already on antibiotics for another reason.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: bronchoscopy intervention group
Group undergoing scheduled bronchoscopy.
Scheduled bronchoscopy.
NO_INTERVENTION: Control group
Standard treatment without scheduled bronchoscopy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
All Cause Mortality
Time Frame: until death or discharge from hospital, data reviewed every 6 months
Bronchoscopy group deaths n=0. Control group deaths n=1.
until death or discharge from hospital, data reviewed every 6 months
Respiratory Associated Mortality
Time Frame: until death or discharge from hospital, data reviewed every 6 months
Bronchoscopy group deaths n=0. Control group deaths n=1.
until death or discharge from hospital, data reviewed every 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of Pneumonia
Time Frame: until discharge from the hospital, data reviewed every 6 months
Bronchoscopy group- 4/13 (31%) Control group- 6/15 (40%)
until discharge from the hospital, data reviewed every 6 months
Length of Mechanical Ventilation
Time Frame: until discharge from hospital, data reviewed every 6 months
Days of mechanical ventilation (bronchoscopy 5.1 days, 95% CI +/- 3.6 days versus control 6.7 days, 95% CI +/- 6.3 days, p = 0.7).
until discharge from hospital, data reviewed every 6 months
Length of ICU Stay
Time Frame: until discharge from hospital, data reviewed every 6 months
Number of ICU days (bronchoscopy 10 days, 95% CI +/- 10 days versus control 18 days, 95% CI +/- 12 days, p = 0.4).
until discharge from hospital, data reviewed every 6 months
Length of Hospital Stay
Time Frame: until discharge from hospital, data reviewed every 6 months
Number of hospital days (bronchoscopy 21 days, 95% CI +/- 12 days versus control 26 days, 95% CI +/- 12 days, p = 0.5).
until discharge from hospital, data reviewed every 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: John A Carr, MD, Hurley Medical Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2009

Primary Completion (ACTUAL)

July 1, 2012

Study Completion (ACTUAL)

July 1, 2012

Study Registration Dates

First Submitted

October 15, 2009

First Submitted That Met QC Criteria

October 16, 2009

First Posted (ESTIMATE)

October 19, 2009

Study Record Updates

Last Update Posted (ESTIMATE)

January 31, 2013

Last Update Submitted That Met QC Criteria

December 22, 2012

Last Verified

December 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pneumonia

Clinical Trials on bronchoscopy

3
Subscribe